Revolutionizing Therapeutics: Advancements in RNA Medicines|Joseph E. Payne, CEO, Arcturus Therapeutics Holdings Inc. 00:10:00

Share On Facebook Share On Twitter

The interview provides insights into the advancements and potential of RNA medicines, highlighting Arcturus Therapeutics' innovative technologies and collaborations in vaccine development, including their work on COVID-19 vaccines. Joseph, the President and CEO, discusses the company's unique platforms, progress in various disease areas, and future prospects, emphasizing the broader impact of messenger RNA beyond COVID-19 vaccines.

Recent Videos